Shalev Varda 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Sep 4, 2024
Insider Transaction Report
Form 4
Shalev Varda
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2024-09-02+12,872→ 12,872 total - Exercise/Conversion
Restricted Share Units
2024-09-02−12,872→ 0 total→ Ordinary Shares (12,872 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on September 2, 2023 and vested on September 2, 2024.